Back to Executive Profile
Alpha

Alpha Profiles · Executive Profile

Keith Regnante

Chief Financial Officer at Keros Therapeutics, Inc. (NASDAQ: KROS)

https://registry.alpha.ac/people/keith-regnante

KR

Generated 2026-11-10T05:40:29.394Z

Data as of 2026-11-10T05:40:29.127304+00:00

https://registry.alpha.ac/people/keith-regnante